Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Economy
Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown
By
Eleanor Pringle
November 6, 2025
Workplace Culture
How pharma giant AbbVie holds leaders accountable for culture
By
Ted Kitterman
and
Great Place To Work
October 9, 2025
North America
Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’
By
Sasha Rogelberg
October 2, 2025
Success
Mark Cuban says his best investment of all time was still living like a student after college—including sleeping on the floor and driving a $200 broken car
By
Jessica Coacci
September 29, 2025
Economy
All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
By
Eva Roytburg
September 26, 2025
Investing
Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
By
Jim Edwards
September 26, 2025
Health
Scientists rebuke Trump’s Tylenol-autism claim, stress fever is bigger danger in pregnancy
By
Jason Gale
and
Bloomberg
September 23, 2025
North America
Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
By
AFP
September 20, 2025
Innovation
The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits
By
Sasha Rogelberg
September 12, 2025
Commentary
A new era of access demands smarter design for direct-to-consumer drug pricing
By
Wendy Barnes
September 5, 2025
Commentary
AI might beat IQ, not EQ — but never say never
By
Paul Hudson
September 2, 2025
Politics
Trump’s plan for hefty tax on imported drugs risks higher prices and shortages
By
Paul Wiseman
,
Tom Murphy
and
The Associated Press
September 1, 2025
Health
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By
Nick Lichtenberg
August 18, 2025
Politics
AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
By
AFP
July 22, 2025
Workplace Culture
Ireland sees thousands of jobs at risk from U.S. pharma tariffs
By
Olivia Fletcher
,
Stephen Carroll
and
Bloomberg
June 23, 2025
Most Popular
AI
Russia's first AI-powered robot walked on stage to triumphant music, took a few steps, and then immediately faceplanted
By
Dave Smith
Future of Work
Ford CEO says he has 5,000 open mechanic jobs with 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Economy
'We are guilty of spending our rainy-day fund in sunny weather': Top economists, historians unite to urge action on $38...
By
Nick Lichtenberg